Pascal Crépey (P Crépey)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Glycemic Control

Respiratory Syndrome Coronavirus

Top Venues

Influenza and other respiratory viruses

Communications medicine

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Fabián P Alvarez, L Allard, F Bianic, Hélène Bricout, Pascal Crépey, J Gaillat, Gaëtan Gavazzi, A Mosnier, Odile Launay, M C Levant, D Proshenska, Caroline de Courville
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population. Journal of medical economics (2024)
Bronke Boudewijns, John Paget, Marco Del Riccio, Laurent Coudeville, Pascal Crépey
Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and other respiratory viruses 17 (1) (2022)
Bronke Boudewijns, John Paget, Marco Del Riccio, Laurent Coudeville, Pascal Crépey
Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and other respiratory viruses (2022)
Bronke Boudewijns, John Paget, Marco Del Riccio, Laurent Coudeville, Pascal Crépey
Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and other respiratory viruses 17 (1) (2022)
Clément R Massonnaud, Jonathan Roux, Vittoria Colizza, Pascal Crépey
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study. Vaccines 10 (3) (2022)
Juliette Paireau, Alessio Andronico, Nathanaël Hozé, Maylis Layan, Pascal Crépey, Alix Roumagnac, Marc Lavielle, Pierre-Yves Boëlle, Simon Cauchemez
An ensemble model based on early predictors to forecast COVID-19 health care demand in France. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Bronke Boudewijns, John Paget, Marco Del Riccio, Laurent Coudeville, Pascal Crépey
Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and other respiratory viruses (2022)
Bronke Boudewijns, John Paget, Marco Del Riccio, Laurent Coudeville, Pascal Crépey
Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and other respiratory viruses 17 (1) (2022)
Laura Di Domenico, Chiara E Sabbatini, Pierre-Yves Boëlle, Chiara Poletto, Pascal Crépey, Juliette Paireau, Simon Cauchemez, François Beck, Harold Noël, Daniel Lévy-Bruhl, Vittoria Colizza
Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic. Communications medicine 1 (1) (2021)
Cécile Tran-Kiem, Paolo Bosetti, Juliette Paireau, Pascal Crépey, Henrik Salje, Noémie Lefrancq, Arnaud Fontanet, Daniel Benamouzig, Pierre-Yves Boëlle, Jean-Claude Desenclos, Lulla Opatowski, Simon Cauchemez
SARS-CoV-2 transmission across age groups in France and implications for control. Nature communications 12 (1) (2021)
Laura Di Domenico, Chiara E Sabbatini, Pierre-Yves Boëlle, Chiara Poletto, Pascal Crépey, Juliette Paireau, Simon Cauchemez, François Beck, Harold Noël, Daniel Lévy-Bruhl, Vittoria Colizza
Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic. Communications medicine 1 (2021)
Pascal Crépey, Esther Redondo, Javier Díez-Domingo, Raul Ortiz de Lejarazu-Leonardo, Federico Martinón-Torres, Ángel Gil de Miguel, Juan Luis López-Belmonte, Fabián P Alvarez, Hélène Bricout, Míriam Solozabal
From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. PloS one 15 (5) (2020)